USX:NEXI - NexImmune, Inc NexImmune, Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 10.7    +0.380 (+3.68%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Aug 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Scott P. Carmer

IPO: 2021-02-12

Headquarters: US

Employees: 44

Homepage

Description

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.